Abnormal VWF modifies megakaryocytopoiesis: studies of platelets and megakaryocyte cultures from patients with von Willebrand disease type 2B.

作者: Paquita Nurden , Giuliana Gobbi , Alan Nurden , Jocelyne Enouf , Ibtissam Youlyouz-Marfak

DOI: 10.1182/BLOOD-2009-07-231886

关键词:

摘要: von Willebrand factor (VWF) is an essential mediator of platelet adhesion to the vessel wall, but little known about its role in megakaryocytopoiesis. VWF and receptor, glycoprotein Ibalpha (GPIbalpha), are both expressed during megakaryocyte (MK) maturation. This study was designed evaluate whether enhanced VWF-GPIbalpha interactions typical patients with disease type 2B (VWD2B) modify production. Platelets from 9 VWD2B 7 different gain-of-function mutations were examined by electron microscopy (EM) immunofluorescence labeling. For VWD2B, EM characteristically showed variable numbers structurally abnormal giant platelets, sometimes agglutinates. Cultures MKs controls performed or without purified confirmed a positive influence on production specific inhibition antibody blocking binding GPIbalpha. MK cultures disorganized demarcation membrane system granule distribution. They produced platelets structural abnormalities VWD2B. Confocal examination revealed limited extension pseudopods few large proplatelets. These results confirm that megakaryocytopoiesis modified interactions. data obtained for suggest novel regulatory

参考文章(37)
Françoise Norol, Natacha Vitrat, Elisabeth Cramer, Josette Guichard, Samuel A. Burstein, William Vainchenker, Najet Debili, Effects of Cytokines on Platelet Production From Blood and Marrow CD34 + Cells Blood. ,vol. 91, pp. 830- 843 ,(1998) , 10.1182/BLOOD.V91.3.830
Christel Poujol, Jerry Ware, Bernhard Nieswandt, Alan T Nurden, Paquita Nurden, Absence of GPIbα is responsible for aberrant membrane development during megakaryocyte maturation Experimental Hematology. ,vol. 30, pp. 352- 360 ,(2002) , 10.1016/S0301-472X(02)00774-9
J. G. Milton, M. M. Frojmovic, S. S. Tang, J. G. White, Spontaneous platelet aggregation in a hereditary giant platelet syndrome (MPS). American Journal of Pathology. ,vol. 114, pp. 336- 345 ,(1984)
J. E. ITALIANO, S. PATEL-HETT, J. H. HARTWIG, Mechanics of proplatelet elaboration Journal of Thrombosis and Haemostasis. ,vol. 5, pp. 18- 23 ,(2007) , 10.1111/J.1538-7836.2007.02487.X
W Robert Colman, Hemostasis and thrombosis : Lippincott Williams & Wilkins,. ,(2013)
L. De Marco, M. Mazzucato, A. Masotti, Z.M. Ruggeri, Localization and characterization of an alpha-thrombin-binding site on platelet glycoprotein Ib alpha. Journal of Biological Chemistry. ,vol. 269, pp. 6478- 6484 ,(1994) , 10.1016/S0021-9258(17)37396-9
D Pidard, R R Montgomery, J S Bennett, T J Kunicki, Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets. Journal of Biological Chemistry. ,vol. 258, pp. 12582- 12586 ,(1983) , 10.1016/S0021-9258(17)44216-5
Barry Coller, Anti-GPIIb/IIIa drugs: current strategies and future directions. Thrombosis and Haemostasis. ,vol. 86, pp. 427- 443 ,(2001) , 10.1055/S-0037-1616241
Paquita Nurden, Fabrice Chretien, Christel Poujol, Joelle Winckler, Annie Borel-Derlon, Alan Nurden, Platelet ultrastructural abnormalities in three patients with type 2B von Willebrand disease. British Journal of Haematology. ,vol. 110, pp. 704- 714 ,(2000) , 10.1046/J.1365-2141.2000.02246.X
Zaverio Ruggeri, Von Willebrand factor: looking back and looking forward. Thrombosis and Haemostasis. ,vol. 98, pp. 55- 62 ,(2007) , 10.1160/TH07-04-0279